Purpose: Prospective study to evaluate consecutive treatment results and to demonstrate safety and efficacy of nonsurgical, exclusive strontium-/yttrium-90 beta-irradiation of nonoperated pterygia.
Patients And Methods: Between November 1999 and March 2002, 20 patients with 21 primary pterygia and six patients with recurrent pterygia after former surgery were treated with exclusive strontium-/yttrium-90 irradiation up to a total dose of 3,600 cGy (six fractions) and 4,800 cGy (eight fractions), respectively. All patients were referred from a single institution. The mean follow-up is 35.6 +/- 7.3 months (range 24-48 months).
Results: Prior to irradiation the mean horizontal diameter of all pterygia was 2.6 mm and shrank to a mean diameter of 1.6 mm after treatment (p = 0.0011, Student's t-test). The treatment led to a reduction in size of all 21 primary and all six recurrent pterygia. Visual acuity reached a value of 0.73 before and 0.82 after treatment. This improvement was not significant in Student's t-test (p = 0.12). The visual acuity did not decrease in any patient, complications were not observed, and in none of the 27 pterygia a recurrence developed
Conclusion: Exclusive strontium-/yttrium-90 irradiation of the early and moderately advanced pterygium is a very efficient and very well-tolerated method of treatment. As to the therapeutic management, it is suggested to apply beta-irradiation prior to the development of an astigmatism-relevant pterygium, which requires excision.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00066-004-1230-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Histopathological effects and evolution of transvenous β-radiation applications in right and left atria: an animal study.
Europace
May 2012
Electrophysiology Service, Montreal Heart Institute, Université de Montréal, 5000 Bélanger St E, Montreal, Quebec, Canada.
Aims: β-radiation is a novel potential energy source for the creation of myocardial lesions. While the feasibility of delivering β-radiation via a deflectable transvenous catheter has been described, dose effects and the time course of histopathological changes have not been previously assessed. The purpose of this study was to characterize pathological aspects of cardiac lesions induced by β-radiation in an animal model at various stages of evolution and in response to different dose exposures.
View Article and Find Full Text PDFProspective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.
Strahlenther Onkol
December 2009
Ophthalmology Clinic Pallas, Olten, Switzerland.
Article Synopsis
- The study aimed to assess the effectiveness of strontium-yttrium-90 beta-irradiation in treating both primary and recurrent pterygia, focusing on recurrence rates and functional outcomes.
- Over a follow-up period averaging nearly 47 months, the treatment successfully reduced the size of all pterygia without any reported recurrences or side effects and improved visual acuity and astigmatism.
- The findings suggest that this beta-irradiation treatment is efficient and well-tolerated, offering better aesthetic and rehabilitative outcomes compared to traditional methods, particularly for recurrent cases after surgery.
Long term results of non-surgical, exclusive strontium-/yttrium-90 beta-irradiation of pterygia.
Radiother Oncol
January 2005
Department of Ophthalmology, Klinik Pallas, Louis-Giroud-Strasse 20, 4600 Olten, Switzerland.
Background And Purpose: To evaluate long term results and to demonstrate safety and efficacy of non-surgical, exclusive strontium-/yttrium-90 beta irradiation of non-operated pterygia.
Patients And Methods: Between March 1977 and April 1999, 43 patients with 54 primary pterygia were treated with an exclusive strontium-/yttrium-90 beta-irradiation up to a total dose of 50 Gy divided in four fractions with one week apart. All patients were referred from the same ophthalmologist.
Beta-radiation for the creation of linear lesions in the canine atrium.
Circulation
August 2004
Department of Medicine and Research Center, Montreal Heart Institute, 5000 Belanger East, Montreal, Quebec, Canada H1T 1C8.
Background: Creating linear lesions is important for the treatment of arrhythmias such as atrial flutter and fibrillation. Making these lesions with standard radiofrequency catheters can be difficult and may result in charring and thrombosis. The purpose of this study was to evaluate beta-radiation as a novel energy source for creating linear myocardial lesions.
View Article and Find Full Text PDFProspective study on exclusive, nonsurgical strontium-/yttrium-90 irradiation of pterygia.
Strahlenther Onkol
August 2004
Ophthalmologic Clinic Pallas, Olten, Switzerland.
Purpose: Prospective study to evaluate consecutive treatment results and to demonstrate safety and efficacy of nonsurgical, exclusive strontium-/yttrium-90 beta-irradiation of nonoperated pterygia.
Patients And Methods: Between November 1999 and March 2002, 20 patients with 21 primary pterygia and six patients with recurrent pterygia after former surgery were treated with exclusive strontium-/yttrium-90 irradiation up to a total dose of 3,600 cGy (six fractions) and 4,800 cGy (eight fractions), respectively. All patients were referred from a single institution.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!